\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ coronal\\ head\\ ultrasound\ \(0\)\
\-\ right\\ intraparenchymal\\ cerebellar\\ hyperechoic\\ region\ \(1\)\
\-\ no\\ midline\\ shift\ \(5\)\
\-\ no\\ intraventricular\\ hemorrhage\ \(1\)\
\-\ no\\ hydrocephalus\ \(5\)\
\-\ surrounding\\ periventricular\\ deep\\ white\\ matter\\ is\\ unremarkable\ \(1\)\
\-\ right\\ intraparenchymal\\ cerebellar\\ hemorrhage\ \(0\)\
\-\ 1\\.\\ intraparenchymal\\ hemorrhage\\ of\\ the\\ right\\ cerebellum\ \(0\)\
\-\ 2\\.\\ tumor\ \(0\)\
\-\ 3\\.\\ operator\\ error\ \(0\)\
\-\ 24\\+5\\ week\\ old\\ female\\ \\(day\\ four\\ of\\ life\\)\\ who\\ is\\ undergoing\\ repeat\\ head\\ ultrasound\\ screening\\ after\\ negative\\ screening\\ on\\ day\\ one\\ of\\ life\\.\ \(1\)\
\-\ intracranial\\ hemorrhage\\ \\(ich\\)\\ is\\ not\\ an\\ uncommon\\ phenomenon\\ in\\ the\\ premature\\ infant\\.\\ \\ with\\ an\\ incidence\\ of\\ 15\\%\\ in\\ neonates\\ less\\ than\\ 1500\\ grams\\ and\\ less\\ than\\ 32\\ weeks\\,\\ it\\ is\\ the\\ most\\ common\\ intracranial\\ abnormality\\ in\\ this\\ subset\\ of\\ patients\\.\\ \\ the\\ incidence\\ doubles\\ \\(30\\%\\)\\ when\\ the\\ infant\\ is\\ less\\ than\\ 28\\ weeks\\ and\\ less\\ than\\ 1000\\ grams\\.\\ \\ the\\ two\\ factors\\ leading\\ to\\ ich\\ in\\ these\\ premature\\ infants\\ are\\ 1\\.\\ instability\\ of\\ the\\ cardiovascular\\ system\\ and\\ 2\\.\\ the\\ absence\\ of\\ an\\ autoregulatory\\ mechanism\\.\\ \\ the\\ first\\ factor\\ leads\\ to\\ sudden\\ fluctuations\\ in\\ systemic\\ blood\\ pressure\\,\\ and\\ without\\ an\\ autoregulatory\\ system\\ these\\ fluctuations\\ are\\ transmitted\\ directly\\ to\\ the\\ vasculature\\ within\\ the\\ brain\\.\\ \\ \ \(0\)\
\-\ ich\\ tends\\ to\\ occur\\ within\\ the\\ first\\ 3\\ days\\ of\\ life\\.\\ \\ within\\ 72\\ to\\ 96\\ hours\\,\\ 80\\%\\ to\\ 90\\%\\ of\\ ich\\ has\\ occurred\\,\\ and\\ it\\ is\\ rare\\ for\\ ich\\ to\\ occur\\ after\\ the\\ first\\ week\\.\\ \\ the\\ classification\\ of\\ papile\\ and\\ colleagues\\ is\\ used\\ to\\ categorize\\ the\\ severity\\ of\\ ich\\ into\\ four\\ grades\\:\ \(0\)\
\-\ \\ grade\\ 1\\ hemorrhage\\ is\\ described\\ as\\ subependymal\\ hemorrhage\\ at\\ the\\ germinal\\ matrix\\.\\ \\ \ \(0\)\
\-\ \\ grade\\ 2\\ occurs\\ when\\ the\\ germinal\\ matrix\\ ruptures\\ through\\ the\\ ependymal\\ wall\\ and\\ enters\\ the\\ lateral\\ ventricle\\.\\ \\ \ \(0\)\
\-\ \\ grade\\ 3\\ intraventricular\\ hemorrhage\\ causes\\ dilatation\\ of\\ one\\ or\\ both\\ lateral\\ ventricular\\ spaces\\,\\ and\\ in\\ its\\ severe\\ form\\ the\\ ventricular\\ cavity\\ may\\ be\\ completely\\ filled\\ with\\ blood\\.\\ \\ \\ \\ \ \(0\)\
\-\ \\ grade\\ 4\\ hemorrhage\\ is\\ described\\ as\\ intraparenchymal\\ hemorrhage\\ with\\ a\\ highly\\ echogenic\\ focus\\ with\\ irregular\\ margins\\ in\\ the\\ parenchyma\\ typically\\ adjacent\\ to\\ the\\ lateral\\ ventricles\\.\\ \\ \ \(0\)\
\-\ the\\ above\\ mentioned\\ case\\ would\\ be\\ classified\\ as\\ a\\ grade\\ 4\\ hemorrhage\\.\\ \\ the\\ hyperechoic\\ focus\\ in\\ the\\ right\\ cerebellum\\ is\\ typical\\ of\\ an\\ intraparenchymal\\ hemorrhage\\ \\(iph\\)\\.\\ \\ the\\ location\\ of\\ the\\ hemorrhage\\ is\\ atypical\\ given\\ that\\ the\\ most\\ common\\ sites\\ of\\ iph\\ are\\ in\\ the\\ frontal\\ and\\ parietal\\ lobes\\.\\ \\ iph\\ is\\ usually\\ associated\\ with\\ intraventricular\\ hemorrhage\\ and\\ ventricular\\ dilation\\;\\ these\\ aspects\\ that\\ are\\ not\\ found\\ in\\ this\\ case\\.\\ \\ an\\ intracerebellar\\ hemorrhage\\ is\\ thought\\ to\\ be\\ caused\\ by\\ one\\ or\\ more\\ of\\ the\\ following\\ three\\ processes\\:\\ primary\\ hemorrhage\\,\\ venous\\ infarct\\,\\ and\\/or\\ extension\\ of\\ a\\ subarachnoid\\/intraventricular\\ hemorrhage\\ into\\ the\\ cerebellum\\.\\ \\ \ \(0\)\
\-\ the\\ prognosis\\ for\\ a\\ grade\\ 4\\ hemorrhage\\ is\\ related\\ to\\ the\\ severity\\ of\\ parenchymal\\ injury\\.\\ \\ major\\ motor\\ deficits\\ will\\ be\\ present\\ in\\ 90\\%\\ of\\ premature\\ infants\\ with\\ iph\\,\\ and\\ greater\\ than\\ 70\\%\\ will\\ have\\ diminished\\ cognitive\\ function\\.\\ \\ more\\ specific\\ to\\ intracerebellar\\ hemorrhage\\ is\\ a\\ high\\ mortality\\ rate\\ in\\ premature\\ infants\\,\\ and\\ term\\ infants\\ with\\ these\\ lesions\\ suffer\\ with\\ significant\\ neurologic\\ deficits\\.\\ \\ given\\ the\\ severe\\ consequences\\ of\\ ich\\,\\ ultrasound\\ screening\\ protocols\\ have\\ been\\ established\\ for\\ premature\\ infants\\.\\ \\ in\\ the\\ asymptomatic\\ premature\\ infant\\,\\ a\\ screening\\ head\\ ultrasound\\ should\\ be\\ performed\\ between\\ the\\ 7th\\ and\\ 14th\\ days\\ of\\ life\\.\\ \\ if\\ no\\ ich\\ is\\ detected\\,\\ then\\ a\\ repeat\\ head\\ ultrasound\\ should\\ be\\ performed\\ at\\ term\\ \\(36\\-40\\ weeks\\)\\.\\ \\ in\\ the\\ symptomatic\\ premature\\ infant\\,\\ the\\ timeframe\\ for\\ ultrasound\\ screening\\ must\\ be\\ individualized\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ich\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.08766544266296\ \(0\)\
\-\ premature\\:\\ 0\\.055815834562068116\ \(0\)\
\-\ iph\\:\\ 0\\.055632679749359946\ \(0\)\
\-\ intraparenchymal\\:\\ 0\\.04863034424689511\ \(0\)\
\-\ infants\\:\\ 0\\.042511736491921574\ \(0\)\
\-\ grade\\:\\ 0\\.0334401040371675\ \(0\)\
\-\ screening\\:\\ 0\\.03120748654904406\ \(0\)\
\-\ \\-no\\:\\ 0\\.031042447097911215\ \(0\)\
\-\ autoregulatory\\:\\ 0\\.03019013158892636\ \(0\)\
\-\ fluctuations\\:\\ 0\\.03019013158892636\ \(0\)\
\-\ intracerebellar\\:\\ 0\\.03019013158892636\ \(0\)\
\-\ infant\\:\\ 0\\.027704341092471458\ \(0\)\
\-\ ultrasound\\:\\ 0\\.02604577998294147\ \(0\)\
\-\ life\\:\\ 0\\.025533712936535027\ \(0\)\
\-\ intraventricular\\:\\ 0\\.025507041895152942\ \(0\)\
\-\ grams\\:\\ 0\\.021978161476603177\ \(0\)\
\-\ cerebellum\\:\\ 0\\.02183820324913696\ \(0\)\
\-\ germinal\\:\\ 0\\.021406058446934797\ \(0\)\
\-\ \\%\\:\\ 0\\.020479325685061722\ \(0\)\
\-\ less\\:\\ 0\\.019821506878922483\ \(0\)\
\-\ ventricular\\:\\ 0\\.01961458638802594\ \(0\)\
\-\ than\\:\\ 0\\.019169938826355083\ \(0\)\
\-\ head\\:\\ 0\\.016600008976533534\ \(0\)\
\-\ matrix\\:\\ 0\\.016344065603191602\ \(0\)\
\-\ severity\\:\\ 0\\.015894284774215277\ \(0\)\
\-\ be\\:\\ 0\\.015795029218163534\ \(0\)\
\-\ is\\:\\ 0\\.015405226805060976\ \(0\)\
\-\ these\\:\\ 0\\.015231812958615342\ \(0\)\
\-\ \\-surrounding\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ 24\\+5\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ doubles\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ papile\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ subarachnoid\\/intraventricular\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ 36\\-40\\:\\ 0\\.01509506579446318\ \(0\)\
\-\ first\\:\\ 0\\.014730223123899926\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.01463090288252224\ \(0\)\
\-\ colleagues\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ categorize\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ timeframe\\:\\ 0\\.013908169937339987\ \(0\)\
\-\ 90\\:\\ 0\\.013794611921864562\ \(0\)\
\-\ repeat\\:\\ 0\\.013766191364279989\ \(0\)\
\-\ incidence\\:\\ 0\\.013416707616491734\ \(0\)\
\-\ deficits\\:\\ 0\\.013391245361397495\ \(0\)\
\-\ term\\:\\ 0\\.013391245361397495\ \(0\)\
\-\ focus\\:\\ 0\\.013146522882006587\ \(0\)\
\-\ 14th\\:\\ 0\\.012721274080216793\ \(0\)\
\-\ four\\:\\ 0\\.01270401695228054\ \(0\)\
\-\ cerebellar\\:\\ 0\\.012621985304943234\ \(0\)\
\-\ described\\:\\ 0\\.012463591408879003\ \(0\)\
\-\ weeks\\:\\ 0\\.012458618614218228\ \(0\)\
\-\ intracranial\\:\\ 0\\.012368190879759254\ \(0\)\
\-\ ruptures\\:\\ 0\\.01233917895810342\ \(0\)\
\-\ consequences\\:\\ 0\\.01233917895810342\ \(0\)\
\-\ 4\\:\\ 0\\.012231020060851258\ \(0\)\
\-\ an\\:\\ 0\\.01214039244128147\ \(0\)\
\-\ operator\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ error\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ 1500\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ subset\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ grades\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ individualized\\:\\ 0\\.012026984511538429\ \(0\)\
\-\ one\\:\\ 0\\.011895880393719062\ \(0\)\
\-\ protocols\\:\\ 0\\.011763027867998604\ \(0\)\
\-\ system\\:\\ 0\\.011522191679454787\ \(0\)\
\-\ enters\\:\\ 0\\.011332694942860065\ \(0\)\
\-\ suffer\\:\\ 0\\.011152283100980227\ \(0\)\
\-\ neonates\\:\\ 0\\.010989080738301588\ \(0\)\
\-\ occur\\:\\ 0\\.010979611742402529\ \(0\)\
\-\ ependymal\\:\\ 0\\.010840088654415235\ \(0\)\
\-\ \\-right\\:\\ 0\\.010703029223467398\ \(0\)\
\-\ transmitted\\:\\ 0\\.010703029223467398\ \(0\)\
\-\ 1000\\:\\ 0\\.010457993532301863\ \(0\)\
\-\ 96\\:\\ 0\\.010145799085736873\ \(0\)\
\-\ 7th\\:\\ 0\\.010145799085736873\ \(0\)\
\-\ in\\:\\ 0\\.010101988393773234\ \(0\)\
\-\ given\\:\\ 0\\.010032241070261447\ \(0\)\
\-\ week\\:\\ 0\\.009938408966877492\ \(0\)\
\-\ cognitive\\:\\ 0\\.009726068849379021\ \(0\)\
\-\ tends\\:\\ 0\\.009653192797292041\ \(0\)\
\-\ phenomenon\\:\\ 0\\.009583292121743659\ \(0\)\
\-\ classified\\:\\ 0\\.009583292121743659\ \(0\)\
\-\ lateral\\:\\ 0\\.009486308453550772\ \(0\)\
\-\ should\\:\\ 0\\.009329481307838356\ \(0\)\
\-\ 2\\.\\:\\ 0\\.009306315554110472\ \(0\)\
\-\ day\\:\\ 0\\.009290958319701814\ \(0\)\
\-\ will\\:\\ 0\\.009155756912257335\ \(0\)\
\-\ 1\\.\\:\\ 0\\.009141058788690414\ \(0\)\
\-\ severe\\:\\ 0\\.009004485616664398\ \(0\)\
\-\ the\\:\\ 0\\.008995672634824965\ \(0\)\
\-\ days\\:\\ 0\\.008969432521136909\ \(0\)\
\-\ established\\:\\ 0\\.008958903228613679\ \(0\)\
\-\ to\\:\\ 0\\.008775372091294238\ \(0\)\
\-\ subependymal\\:\\ 0\\.008736209515859914\ \(0\)\
\-\ mentioned\\:\\ 0\\.008736209515859914\ \(0\)\
\-\ periventricular\\:\\ 0\\.008430989941534026\ \(0\)\
\-\ aspects\\:\\ 0\\.008430989941534026\ \(0\)\
\-\ when\\:\\ 0\\.00838127136169865\ \(0\)\
\-\ within\\:\\ 0\\.008373962714312063\ \(0\)\
\-\ classification\\:\\ 0\\.008362487656236596\ \(0\)\
\-\ 72\\:\\ 0\\.008296620737010919\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.00820234029662902\ \(0\)\
\-\ leads\\:\\ 0\\.008172032801595801\ \(0\)\
\-\ performed\\:\\ 0\\.00815951483297027\ \(0\)\
\-\ directly\\:\\ 0\\.008028054861166792\ \(0\)\
\-\ diminished\\:\\ 0\\.008000657016395489\ \(0\)\
\-\ blood\\:\\ 0\\.007987709152429107\ \(0\)\
\-\ are\\:\\ 0\\.00797858816801097\ \(0\)\
\-\ sites\\:\\ 0\\.007973690651724017\ \(0\)\
\-\ mortality\\:\\ 0\\.007973690651724017\ \(0\)\
\-\ vasculature\\:\\ 0\\.007947142387107638\ \(0\)\
\-\ processes\\:\\ 0\\.007920999455376835\ \(0\)\
\-\ occurred\\:\\ 0\\.007748388669209088\ \(0\)\
\-\ detected\\:\\ 0\\.007725091319798507\ \(0\)\
\-\ common\\:\\ 0\\.007658449356015058\ \(0\)\
\-\ instability\\:\\ 0\\.007528557904400514\ \(0\)\
\-\ mechanism\\:\\ 0\\.007528557904400514\ \(0\)\
\-\ factor\\:\\ 0\\.007467758780330462\ \(0\)\
\-\ more\\:\\ 0\\.007319096949699199\ \(0\)\
\-\ 32\\:\\ 0\\.007297331391037598\ \(0\)\
\-\ echogenic\\:\\ 0\\.007279401083045654\ \(0\)\
\-\ spaces\\:\\ 0\\.007209500407497271\ \(0\)\
\-\ parenchymal\\:\\ 0\\.007192462169734997\ \(0\)\
\-\ undergoing\\:\\ 0\\.007175591799113402\ \(0\)\
\-\ uncommon\\:\\ 0\\.007158886020097367\ \(0\)\
\-\ highly\\:\\ 0\\.007046298044818633\ \(0\)\
\-\ completely\\:\\ 0\\.007030801751120144\ \(0\)\
\-\ 70\\:\\ 0\\.007030801751120144\ \(0\)\
\-\ leading\\:\\ 0\\.007000223639133831\ \(0\)\
\-\ systemic\\:\\ 0\\.007000223639133831\ \(0\)\
\-\ into\\:\\ 0\\.006963446465615434\ \(0\)\
\-\ shift\\:\\ 0\\.006940658371864284\ \(0\)\
\-\ prognosis\\:\\ 0\\.006940658371864284\ \(0\)\
\-\ 28\\:\\ 0\\.006897305960932281\ \(0\)\
\-\ dilation\\:\\ 0\\.006897305960932281\ \(0\)\
\-\ 80\\:\\ 0\\.006883095682139994\ \(0\)\
\-\ ventricles\\:\\ 0\\.006883095682139994\ \(0\)\
\-\ 3\\:\\ 0\\.00685265591337856\ \(0\)\
\-\ form\\:\\ 0\\.006841159004043597\ \(0\)\
\-\ major\\:\\ 0\\.006841159004043597\ \(0\)\
\-\ filled\\:\\ 0\\.006800224892992991\ \(0\)\
\-\ sudden\\:\\ 0\\.0067602465299844445\ \(0\)\
\-\ most\\:\\ 0\\.006756284731945466\ \(0\)\
\-\ thought\\:\\ 0\\.006734103598253642\ \(0\)\
\-\ must\\:\\ 0\\.006670440921469817\ \(0\)\
\-\ margins\\:\\ 0\\.006645624128143504\ \(0\)\
\-\ as\\:\\ 0\\.0066399529412369575\ \(0\)\
\-\ it\\:\\ 0\\.006578247892236358\ \(0\)\
\-\ factors\\:\\ 0\\.006573261441003293\ \(0\)\
\-\ infarct\\:\\ 0\\.006492530656027777\ \(0\)\
\-\ lobes\\:\\ 0\\.006448052083419454\ \(0\)\
\-\ cavity\\:\\ 0\\.00640469967248745\ \(0\)\
\-\ case\\:\\ 0\\.0064024124413262695\ \(0\)\
\-\ atypical\\:\\ 0\\.00634166204727732\ \(0\)\
\-\ have\\:\\ 0\\.006337116706729766\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0062908473757942425\ \(0\)\
\-\ dilatation\\:\\ 0\\.006270936351829998\ \(0\)\
\-\ parietal\\:\\ 0\\.006251254195279082\ \(0\)\
\-\ parenchyma\\:\\ 0\\.0062317957044395016\ \(0\)\
\-\ function\\:\\ 0\\.006203016392253917\ \(0\)\
\-\ \\(\\:\\ 0\\.006184603820580998\ \(0\)\
\-\ and\\/or\\:\\ 0\\.006184095439879627\ \(0\)\
\-\ caused\\:\\ 0\\.00613768802587656\ \(0\)\
\-\ motor\\:\\ 0\\.006110435533914404\ \(0\)\
\-\ neurologic\\:\\ 0\\.006110435533914404\ \(0\)\
\-\ \\)\\:\\ 0\\.006109055583161859\ \(0\)\
\-\ coronal\\:\\ 0\\.00609250522592246\ \(0\)\
\-\ absence\\:\\ 0\\.006083609991543857\ \(0\)\
\-\ after\\:\\ 0\\.006054798639072611\ \(0\)\
\-\ specific\\:\\ 0\\.006048484067172105\ \(0\)\
\-\ related\\:\\ 0\\.006039814029575279\ \(0\)\
\-\ \\,\\:\\ 0\\.006026080225556054\ \(0\)\
\-\ occurs\\:\\ 0\\.006005566312611803\ \(0\)\
\-\ deep\\:\\ 0\\.00592282902276453\ \(0\)\
\-\ typical\\:\\ 0\\.005867203243407529\ \(0\)\
\-\ 15\\:\\ 0\\.005836210021415033\ \(0\)\
\-\ irregular\\:\\ 0\\.005836210021415033\ \(0\)\
\-\ symptomatic\\:\\ 0\\.005813327782010637\ \(0\)\
\-\ matter\\:\\ 0\\.0057610958397273935\ \(0\)\
\-\ hours\\:\\ 0\\.00575376251474109\ \(0\)\
\-\ pressure\\:\\ 0\\.005746460462024553\ \(0\)\
\-\ rate\\:\\ 0\\.005703290223417539\ \(0\)\
\-\ causes\\:\\ 0\\.0056961998250168\ \(0\)\
\-\ rare\\:\\ 0\\.005682106504577561\ \(0\)\
\-\ midline\\:\\ 0\\.005661181656401577\ \(0\)\
\-\ 30\\:\\ 0\\.005626865302149101\ \(0\)\
\-\ used\\:\\ 0\\.005613329035869797\ \(0\)\
\-\ its\\:\\ 0\\.005521457951122673\ \(0\)\
\-\ greater\\:\\ 0\\.005496089653545378\ \(0\)\
\-\ ventricle\\:\\ 0\\.005483545064346623\ \(0\)\
\-\ abnormality\\:\\ 0\\.0053982156572440956\ \(0\)\
\-\ above\\:\\ 0\\.005362908658609274\ \(0\)\
\-\ venous\\:\\ 0\\.00531127674393344\ \(0\)\
\-\ n\\/a\\:\\ 0\\.005300011382464189\ \(0\)\
\-\ extension\\:\\ 0\\.005223163221201461\ \(0\)\
\-\ would\\:\\ 0\\.005207135065791249\ \(0\)\
\-\ then\\:\\ 0\\.005207135065791249\ \(0\)\
\-\ typically\\:\\ 0\\.005165112619017076\ \(0\)\
\-\ location\\:\\ 0\\.0051039515186710495\ \(0\)\
\-\ that\\:\\ 0\\.005054728522461724\ \(0\)\
\-\ 3\\.\\:\\ 0\\.005006633924898506\ \(0\)\
\-\ for\\:\\ 0\\.004993891429059693\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.004946219859582341\ \(0\)\
\-\ three\\:\\ 0\\.004932575733470736\ \(0\)\
\-\ white\\:\\ 0\\.004852918172452085\ \(0\)\
\-\ unremarkable\\:\\ 0\\.004844291812811747\ \(0\)\
\-\ a\\:\\ 0\\.0047537647478256995\ \(0\)\
\-\ injury\\:\\ 0\\.004664740653919178\ \(0\)\
\-\ between\\:\\ 0\\.004637834822301787\ \(0\)\
\-\ right\\:\\ 0\\.004631669738580907\ \(0\)\
\-\ adjacent\\:\\ 0\\.004626431924887444\ \(0\)\
\-\ found\\:\\ 0\\.004611345230226219\ \(0\)\
\-\ frontal\\:\\ 0\\.004596390298772872\ \(0\)\
\-\ usually\\:\\ 0\\.004443370297717053\ \(0\)\
\-\ brain\\:\\ 0\\.004402999183737606\ \(0\)\
\-\ negative\\:\\ 0\\.004370068769477525\ \(0\)\
\-\ primary\\:\\ 0\\.00433456209399948\ \(0\)\
\-\ wall\\:\\ 0\\.004238286164792373\ \(0\)\
\-\ not\\:\\ 0\\.0042288310676093675\ \(0\)\
\-\ two\\:\\ 0\\.004190635680849325\ \(0\)\
\-\ of\\:\\ 0\\.004189349001297529\ \(0\)\
\-\ through\\:\\ 0\\.004155748319213816\ \(0\)\
\-\ following\\:\\ 0\\.004152872871406076\ \(0\)\
\-\ region\\:\\ 0\\.004132878813765946\ \(0\)\
\-\ and\\:\\ 0\\.004007049785135\ \(0\)\
\-\ high\\:\\ 0\\.0040043596936246845\ \(0\)\
\-\ been\\:\\ 0\\.003980813166890395\ \(0\)\
\-\ if\\:\\ 0\\.003970451085240814\ \(0\)\
\-\ at\\:\\ 0\\.003964942304217921\ \(0\)\
\-\ significant\\:\\ 0\\.003934669779202437\ \(0\)\
\-\ lesions\\:\\ 0\\.003917055661547856\ \(0\)\
\-\ \\:\\:\\ 0\\.0038708041643515925\ \(0\)\
\-\ who\\:\\ 0\\.003815014399215243\ \(0\)\
\-\ patients\\:\\ 0\\.003786942807133606\ \(0\)\
\-\ both\\:\\ 0\\.0037366438196680157\ \(0\)\
\-\ 1\\:\\ 0\\.003481723232807717\ \(0\)\
\-\ \\;\\:\\ 0\\.0034681869665284136\ \(0\)\
\-\ associated\\:\\ 0\\.0034528468525816813\ \(0\)\
\-\ without\\:\\ 0\\.0034452280245858904\ \(0\)\
\-\ or\\:\\ 0\\.0034298724279579022\ \(0\)\
\-\ tumor\\:\\ 0\\.00341135668084043\ \(0\)\
\-\ present\\:\\ 0\\.0033048095101569875\ \(0\)\
\-\ this\\:\\ 0\\.003291565799021003\ \(0\)\
\-\ may\\:\\ 0\\.0032094663850995267\ \(0\)\
\-\ 2\\:\\ 0\\.0031508638638879215\ \(0\)\
\-\ female\\:\\ 0\\.003008151149739441\ \(0\)\
\-\ has\\:\\ 0\\.002747773922079243\ \(0\)\
\-\ by\\:\\ 0\\.002436422779528895\ \(0\)\
\-\ with\\:\\ 0\\.0016027969327382155\ \(0\)\
\-\ old\\:\\ 0\\.001498175679558655\ \(0\)\
\-\ no\\:\\ 0\\.0014733632717530854\ \(0\)\
\-\ \\.\\:\\ 0\\.001458885045096422\ \(0\)\
\-\ on\\:\\ 0\\.001239539404735322\ \(0\)\
